Helping our patient communities and advancing knowledge in our therapy areas is part of our corporate responsibility.
It is our mission to discover, develop, and deliver innovative therapies that improve patients' quality of life.
We work with government authorities to ensure patients have access to care while also funding medical research.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
Every day at CSL Behring, we work as if someone’s life depends on it, because it does.
CSL Behring biotherapies are manufactured in state-of-the-art facilities under stringent, controlled conditions.
Help us deliver on our promise to save lives and protect the health of people.
Make your well-being a priority. It's important and so are you.
Rare disease patients on where they look for support in managing their condition.
Creator of Teal Pumpkin Project shares advice on how to advocate for your children.
Annual summit focuses on improving lives of rare disease patients.
Caroline, a CIDP patient, created a canvas of light and hope to capture the treatment phase.
Leaders ring the opening bell in Sydney and reflect on the company’s transformation into a global biotechnology business.
Patients with primary immune deficiency disease are more at risk, but there’s help and hope.
CSL Behring construction project in Switzerland follows the custom of “topping out.”
Employees get vaccinated ahead of peak flu season in northern hemisphere.
Patients share their strategies for managing stress while living with a rare condition.
An end to confusion: CIDP patient Darryl paints the relief of diagnosis.
Watch a short animation about teaching kids to self-infuse.
“Hope Lives Here” connects Jamaican teens living with blood disorder.
Popular search terms:
Americas
Asia Pacific
Europe
